OAM
VRTX icon

Ostrum Asset Management’s Vertex Pharmaceuticals VRTX Stock Holding History

Ostrum Asset Management’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$697K Hold
1,403
– – 0.03% 276
2026
Q1 		$626K Sell
1,403
-2,846
-67% -$1.33M 0.04% 284
2025
Q4 		$1.93M Sell
4,249
-1,170
-22% -$504K 0.09% 168
2025
Q3 		$2.12M Sell
5,419
-475
-8% -$199K 0.1% 187
2025
Q2 		$2.62M Sell
5,894
-452
-7% -$208K 0.12% 158
2025
Q1 		$3.08M Sell
6,346
-13
-0.2% -$6.06K 0.16% 118
2024
Q4 		$2.56M Buy
6,359
+1,086
+21% +$503K 0.22% 141
2024
Q3 		$2.45M Sell
5,273
-2,155
-29% -$1.04M 0.2% 180
2024
Q2 		$3.48M Sell
7,428
-1,893
-20% -$822K 0.3% 86
2024
Q1 		$3.9M Buy
9,321
+15
+0.2% +$6.34K 0.31% 85
2023
Q4 		$3.79M Buy
9,306
+477
+5% +$176K 0.33% 80
2023
Q3 		$3.07M Sell
8,829
-60
-0.7% -$21K 0.28% 93
2023
Q2 		$3.13M Buy
8,889
+8
+0.1% +$2.69K 0.26% 120
2023
Q1 		$2.8M Buy
+8,881
New +$2.66M 0.24% 137
2020
Q3 		$3.65M Buy
13,405
+1,010
+8% +$279K 2.35% 12
2020
Q2 		$3.6M Buy
12,395
+1,700
+16% +$461K 2.14% 11
2020
Q1 		$2.54M Buy
10,695
+1,100
+11% +$252K 1.75% 12
2019
Q4 		$2.1M Hold
9,595
– – 1% 22
2019
Q3 		$1.63M Buy
9,595
+900
+10% +$159K 0.81% 30
2019
Q2 		$1.59M Buy
8,695
+5,042
+138% +$881K 0.44% 78
2019
Q1 		$672K Hold
3,653
– – 0.22% 120
2018
Q4 		$605K Buy
+3,653
New +$633K 0.24% 117

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Ostrum Asset Management's VRTX Position: Q2 2026 in Review

Ostrum Asset Management held its Vertex Pharmaceuticals (VRTX) position steady in Q2 2026 at 1,403 shares worth $697K. The position accounts for 0.03% of the portfolio, ranked #276.

Ostrum Asset Management first reported a position in VRTX in Q4 2018 and has held it in 22 quarters since. The position peaked at $3.9M in Q1 2024. 1,757 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

  • Ostrum Asset Management held 1,403 shares of Vertex Pharmaceuticals worth $697K as of Q2 2026.
  • Ostrum Asset Management left its Vertex Pharmaceuticals share count unchanged in Q2 2026.
  • Vertex Pharmaceuticals made up 0.03% of Ostrum Asset Management's portfolio in Q2 2026, its #276 holding.
  • Ostrum Asset Management first reported a position in Vertex Pharmaceuticals in Q4 2018 and has held it in 22 quarters since.
  • Ostrum Asset Management's Vertex Pharmaceuticals position peaked at $3.9M in Q1 2024.
  • 1,757 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on Ostrum Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.